SlideShare una empresa de Scribd logo
1 de 35
•   Definition
•   Prognosis
•   Pathology
•   Risk factor
•   Incidence
•   Prevention
•   Recommendation
Case 1
• 69 y/o M with NSTEMI is going for PCI.
  Baseline Cr 65. 2 days post PCI Cr is 94 with
  good UOP .

• Are you concerned about what happened?
Case 2
• 42 y/o F in 5C3 with T2 DM with baseline Cr
  of 60 she is scheduled for CT abdomen for
  pancreatitis .

• What is her risk of developing CIN?
Case 3
• 78 y/o came with IWMI with hypotension
  required IABP and pressors is going for
  diagnostic angiogram after successful lytic
  therapy . Known DM with Cr 150 ,he is
  concerned about his kidneys .

• Is there a way to predict his risk ?
Case 4
• 65 y/o F smoker ,T2 DM with Cr 100,HTN and
  sever PVD underwent 1ry PCI for AWMI. Next
  day Cr 200 and you notice periphral cynosis
  with rash over Rt leg.

• What is happening with her?
Types of radiocontrast agents

• First generation agents are ionic hyperosmolal
  monomers( 1500)
• Second generation agents are nonionic
  monomers with a lower osmolality than the
  first generation (600)
• The nonionic contrast agents are dimers with
  an osmolality ( 350)
Definition


25% rise in serum creatinine during the first
  three days after the procedure is the most
             acceptable definition .
Prognosis
• Peak in 1-3 days
• Recovery 5-10
• If creatinine >440 moslt likely progress to RF
  requiring HD.
PATHOGENESIS
The exact mechanism is not well understood .
The two major theories, based mainly on animal
  studies:
        renal vasoconstriction(endothelin)
   direct toxic effects of the contrast agents.
INCIDENCE AND RISK FACTORS


The reported incidence of radiocontrast-
induced nephropathy varies widely, ranging
from 0- 50%.
Who is in risk
• Underlying renal insufficiency, with the plasma
 creatinine exceeding 132 µmol/L(4-11%) and 50% if
 exceeding 350µmol/L.
• Diabetic nephropathy with renal insufficiency (9-
 30%)
• Multiple myeloma (1.5%)
• Advanced heart failure or other cause of reduced
 renal perfusion such as hypovolemia
• High total dose of contrast agent and the type of
 the contrast
Normal kidney function

Negligible with normal renal function, even if
            the patient is diabetic
In PCI
In a review of over 7500 patients undergoing a
 PCI for coronary heart disease, the incidence
 of CIN was 3.3 percent overall and
 approximately 25 percent in those with a
 baseline serum creatinine above (177 µmol/L)
 .
PREVENTION
Which of the following modalities can
               prevent CIN?
•    Lasix
•    Manitol
•    Dobutamin
•    Theophyline
•    Ca blockers
•    ANP
•    UF
•    HD
•    Statin
Effective
• Hydration
• NAC
• NaHCO3
Oral hydration
• Few small trials have evaluated the
  effectiveness of oral hydration or an
  outpatient hydration protocol in preventing
  contrast nephropathy.
• The results have been conflicting, some
  suggested that oral hydration as effective
  others less effective .
Type of fluid
• Prospective randomized trial of 1620
  patients . The incidence of contrast-induced
  nephropathy was significantly lower in
  patients received NS than 1/2NS
Acetylcysteine
• There is inconsistency in the results of clinical
  trials regarding the effectiveness of NAC in
  prevention of contrast nephropathy .
• The overall direction of the data is towards
  benefit .
NaHCO3
• A prospective, single-center, randomized trial
  showed overall benefit of NaHCO3 compared
  to NS .
• Issues with this study
SUMMARY AND RECOMMENDATIONS

• Indication of the procedure

• The use of lower doses of contrast and avoidance of
  repetitive studies that are closely spaced.

• Avoid of volume depletion

• Avoid NSAID

• Stop metformin 48h before
Hydration

Prophylactic regimen is the intravenous
administration of NS at a rate of 1 mL/kg /h for 12
hours before and 12 hours after the radiographic
study .
NAC
PO: 600 mg orally BID and administered the day
 before and the day of the procedure .



IV: 150 mg/kg in 500 mL NS over 30 minutes
  immediately before contrast exposure, then
  50 mg/kg in 500 mL NS over four hours .
NaHCO3
• A bolus of 3 mL/kg of NaHCO3 one hour prior
  to the procedure, and continued at a rate of 1
  mL/kg for six hours after the procedure.
Contrast
Both low osmolal and iso-osmolal nonionic
  agents appear to lower the risk of
  nephropathy .
HD and UF
•   Creatinine >440
•   Decrease UOP
•   Acidosis
•   Hyperkalemia
Case 1
• 62 y/o M with NSTEMI is going for PCI.
  Baseline Cr 65. 2 days post PCI Cr is 94 with
  good UOP .

• Are you concerned about what happened?
Case 2
• 42 y/o F in 5C3 with T2 DM with baseline Cr
  of 60 she is scheduled for CT abdomen for
  pancreatitis .

• What is her risk of developing CIN?
Case 3
• 78 y/o came with IWMI with hypotension
  requiring IABP is going for diagnostic
  angiogram after successful lytic therapy .
  Known DM with Cr 150 is concerned about his
  kidney function.

• Is there a way to predict his risk ?
Case 4
• 65 y/o F smoker ,T2 DM with Cr 100,HTN and
  sever PVD underwent 1ry PCI for AWMI. Next
  day Cr 200 and you notice periphral cynosis
  with rash over Rt leg.

• What is happening with her?
Cholesterol embolism
•   Low complement
•   Eosinophilia
•   Eosinophilurea
•   Systemic ischemia
•   Acute deterioration
•   Last upto 8 weeks
•   Livedo reticularis
THANKS

Más contenido relacionado

La actualidad más candente

Contrast Induced Nephropathy
Contrast Induced NephropathyContrast Induced Nephropathy
Contrast Induced NephropathyRamachandra Barik
 
CONTRAST INDUCED NEPHROPATHY(CI-AKI)
CONTRAST INDUCED NEPHROPATHY(CI-AKI)CONTRAST INDUCED NEPHROPATHY(CI-AKI)
CONTRAST INDUCED NEPHROPATHY(CI-AKI)Praveen Nagula
 
CONTRAST INDUCED NEPHROPATHY
CONTRAST INDUCED NEPHROPATHYCONTRAST INDUCED NEPHROPATHY
CONTRAST INDUCED NEPHROPATHYfareedresidency
 
Contrast Nephropathy AKI
Contrast Nephropathy AKI  Contrast Nephropathy AKI
Contrast Nephropathy AKI Manish Singla
 
Contrast Induce Nephropathy
Contrast Induce NephropathyContrast Induce Nephropathy
Contrast Induce NephropathyZiyad Salih
 
Contrast Induced Nephropathy
Contrast Induced NephropathyContrast Induced Nephropathy
Contrast Induced NephropathyWaleed El-Refaey
 
Contrast Induced Nephropathy
Contrast Induced NephropathyContrast Induced Nephropathy
Contrast Induced Nephropathyvishwanath69
 
Hydration for contrast induced nephropathy
Hydration for contrast induced nephropathyHydration for contrast induced nephropathy
Hydration for contrast induced nephropathyWisit Cheungpasitporn
 
Prevention is easier than solving the problem
Prevention is easier than solving the problemPrevention is easier than solving the problem
Prevention is easier than solving the problemBuddhika Illeperuma
 
12: 50 Boudou - Prevention of contrast - induced nephropathy
12: 50 Boudou - Prevention of contrast - induced nephropathy12: 50 Boudou - Prevention of contrast - induced nephropathy
12: 50 Boudou - Prevention of contrast - induced nephropathyEuro CTO Club
 
Contrast induced nephropathy-the truth and myth
Contrast induced nephropathy-the truth and mythContrast induced nephropathy-the truth and myth
Contrast induced nephropathy-the truth and mythTarek Samy
 
B cell malignancies and the Kidney
B cell malignancies and the KidneyB cell malignancies and the Kidney
B cell malignancies and the Kidneykdj200
 
Luca Grancini - Contrast management
Luca Grancini - Contrast management Luca Grancini - Contrast management
Luca Grancini - Contrast management Euro CTO Club
 
Acute kidney injury in critically ill patients in the new millenium: definiti...
Acute kidney injury in critically ill patients in the new millenium: definiti...Acute kidney injury in critically ill patients in the new millenium: definiti...
Acute kidney injury in critically ill patients in the new millenium: definiti...Vall d'Hebron Institute of Research (VHIR)
 
Perioperative acute kidney injury
Perioperative acute kidney injuryPerioperative acute kidney injury
Perioperative acute kidney injuryAndrew Ferguson
 
Aki biomarker 2016 chaken maniyan
Aki biomarker 2016 chaken maniyanAki biomarker 2016 chaken maniyan
Aki biomarker 2016 chaken maniyanCHAKEN MANIYAN
 

La actualidad más candente (20)

Contrast Induced Nephropathy
Contrast Induced NephropathyContrast Induced Nephropathy
Contrast Induced Nephropathy
 
CONTRAST INDUCED NEPHROPATHY(CI-AKI)
CONTRAST INDUCED NEPHROPATHY(CI-AKI)CONTRAST INDUCED NEPHROPATHY(CI-AKI)
CONTRAST INDUCED NEPHROPATHY(CI-AKI)
 
CONTRAST INDUCED NEPHROPATHY
CONTRAST INDUCED NEPHROPATHYCONTRAST INDUCED NEPHROPATHY
CONTRAST INDUCED NEPHROPATHY
 
Contrast Nephropathy AKI
Contrast Nephropathy AKI  Contrast Nephropathy AKI
Contrast Nephropathy AKI
 
Contrast Induce Nephropathy
Contrast Induce NephropathyContrast Induce Nephropathy
Contrast Induce Nephropathy
 
Contrast Induced Nephropathy
Contrast Induced NephropathyContrast Induced Nephropathy
Contrast Induced Nephropathy
 
Contrast Induced Nephropathy
Contrast Induced NephropathyContrast Induced Nephropathy
Contrast Induced Nephropathy
 
Hydration for contrast induced nephropathy
Hydration for contrast induced nephropathyHydration for contrast induced nephropathy
Hydration for contrast induced nephropathy
 
Prevention is easier than solving the problem
Prevention is easier than solving the problemPrevention is easier than solving the problem
Prevention is easier than solving the problem
 
12: 50 Boudou - Prevention of contrast - induced nephropathy
12: 50 Boudou - Prevention of contrast - induced nephropathy12: 50 Boudou - Prevention of contrast - induced nephropathy
12: 50 Boudou - Prevention of contrast - induced nephropathy
 
Contrast induced nephropathy-the truth and myth
Contrast induced nephropathy-the truth and mythContrast induced nephropathy-the truth and myth
Contrast induced nephropathy-the truth and myth
 
Preserve trial 2018
Preserve trial 2018Preserve trial 2018
Preserve trial 2018
 
CIN
CINCIN
CIN
 
B cell malignancies and the Kidney
B cell malignancies and the KidneyB cell malignancies and the Kidney
B cell malignancies and the Kidney
 
Luca Grancini - Contrast management
Luca Grancini - Contrast management Luca Grancini - Contrast management
Luca Grancini - Contrast management
 
Critical care nephrology
Critical care nephrologyCritical care nephrology
Critical care nephrology
 
Acute kidney injury in critically ill patients in the new millenium: definiti...
Acute kidney injury in critically ill patients in the new millenium: definiti...Acute kidney injury in critically ill patients in the new millenium: definiti...
Acute kidney injury in critically ill patients in the new millenium: definiti...
 
Perioperative acute kidney injury
Perioperative acute kidney injuryPerioperative acute kidney injury
Perioperative acute kidney injury
 
Obesity paradox
Obesity paradoxObesity paradox
Obesity paradox
 
Aki biomarker 2016 chaken maniyan
Aki biomarker 2016 chaken maniyanAki biomarker 2016 chaken maniyan
Aki biomarker 2016 chaken maniyan
 

Similar a Contrast nephropahthy

Prevention-of-contrast-induced-nephropathy-_1_.ppt
Prevention-of-contrast-induced-nephropathy-_1_.pptPrevention-of-contrast-induced-nephropathy-_1_.ppt
Prevention-of-contrast-induced-nephropathy-_1_.pptvarshithkumar4
 
Inquisito-AIIMS Medicine Quiz 2021 - Prelims
Inquisito-AIIMS Medicine Quiz 2021 - PrelimsInquisito-AIIMS Medicine Quiz 2021 - Prelims
Inquisito-AIIMS Medicine Quiz 2021 - PrelimsAakanshaKumari4
 
PCI complications
PCI complicationsPCI complications
PCI complicationsIqbal Dar
 
Immune thrombocyopenia (ITP)
Immune thrombocyopenia (ITP)Immune thrombocyopenia (ITP)
Immune thrombocyopenia (ITP)Ankit Raiyani
 
Acute pancreatitis
Acute  pancreatitisAcute  pancreatitis
Acute pancreatitisbarun kumar
 
Post chemotherapy care ver 1.0
Post chemotherapy care ver 1.0Post chemotherapy care ver 1.0
Post chemotherapy care ver 1.0Vivek Verma
 
Gastrocon 2016 - Acute Liver Failure
Gastrocon 2016 - Acute Liver FailureGastrocon 2016 - Acute Liver Failure
Gastrocon 2016 - Acute Liver FailureApolloGleaneagls
 
Ca Papillary(Thyroid Gland)
Ca Papillary(Thyroid Gland)Ca Papillary(Thyroid Gland)
Ca Papillary(Thyroid Gland)DRASIMSHAHZAD1
 
Anaesthesia for renal transplantation
Anaesthesia for renal transplantationAnaesthesia for renal transplantation
Anaesthesia for renal transplantationSouvik Maitra
 
Aki an overview
Aki an overviewAki an overview
Aki an overviewFAARRAG
 
Initial Therapy in CLL
Initial Therapy in CLLInitial Therapy in CLL
Initial Therapy in CLLroysudip900
 
Endocinology lectures (adrenal disorders)
Endocinology lectures (adrenal disorders)Endocinology lectures (adrenal disorders)
Endocinology lectures (adrenal disorders)Ahmed Elshebiny
 
Acute Medicine Skills Part One
Acute Medicine Skills Part OneAcute Medicine Skills Part One
Acute Medicine Skills Part OneRecoveryPackage
 

Similar a Contrast nephropahthy (20)

Prevention-of-contrast-induced-nephropathy-_1_.ppt
Prevention-of-contrast-induced-nephropathy-_1_.pptPrevention-of-contrast-induced-nephropathy-_1_.ppt
Prevention-of-contrast-induced-nephropathy-_1_.ppt
 
Inquisito-AIIMS Medicine Quiz 2021 - Prelims
Inquisito-AIIMS Medicine Quiz 2021 - PrelimsInquisito-AIIMS Medicine Quiz 2021 - Prelims
Inquisito-AIIMS Medicine Quiz 2021 - Prelims
 
PCI complications
PCI complicationsPCI complications
PCI complications
 
Immune thrombocyopenia (ITP)
Immune thrombocyopenia (ITP)Immune thrombocyopenia (ITP)
Immune thrombocyopenia (ITP)
 
Acute pancreatitis
Acute  pancreatitisAcute  pancreatitis
Acute pancreatitis
 
Oncologic emergencies asim
Oncologic emergencies asimOncologic emergencies asim
Oncologic emergencies asim
 
Post chemotherapy care ver 1.0
Post chemotherapy care ver 1.0Post chemotherapy care ver 1.0
Post chemotherapy care ver 1.0
 
Gastrocon 2016 - Acute Liver Failure
Gastrocon 2016 - Acute Liver FailureGastrocon 2016 - Acute Liver Failure
Gastrocon 2016 - Acute Liver Failure
 
Nsgct
NsgctNsgct
Nsgct
 
Ca Papillary(Thyroid Gland)
Ca Papillary(Thyroid Gland)Ca Papillary(Thyroid Gland)
Ca Papillary(Thyroid Gland)
 
Anaesthesia for renal transplantation
Anaesthesia for renal transplantationAnaesthesia for renal transplantation
Anaesthesia for renal transplantation
 
Aki an overview
Aki an overviewAki an overview
Aki an overview
 
Initial Therapy in CLL
Initial Therapy in CLLInitial Therapy in CLL
Initial Therapy in CLL
 
Emergencies in oncology
Emergencies in oncologyEmergencies in oncology
Emergencies in oncology
 
Pulmonary embolism
Pulmonary embolismPulmonary embolism
Pulmonary embolism
 
ACS:STEMI
ACS:STEMIACS:STEMI
ACS:STEMI
 
Endocinology lectures (adrenal disorders)
Endocinology lectures (adrenal disorders)Endocinology lectures (adrenal disorders)
Endocinology lectures (adrenal disorders)
 
Neonatal septic shock
Neonatal septic shockNeonatal septic shock
Neonatal septic shock
 
Acute Medicine Skills Part One
Acute Medicine Skills Part OneAcute Medicine Skills Part One
Acute Medicine Skills Part One
 
CIN.pptx
CIN.pptxCIN.pptx
CIN.pptx
 

Más de Mohammed Alsheikh (15)

Cv arabic
Cv arabicCv arabic
Cv arabic
 
Curriculum vitae
Curriculum vitaeCurriculum vitae
Curriculum vitae
 
Syncope
SyncopeSyncope
Syncope
 
Rheumatic fever
Rheumatic feverRheumatic fever
Rheumatic fever
 
Pericarditis
PericarditisPericarditis
Pericarditis
 
Osteoporosis
OsteoporosisOsteoporosis
Osteoporosis
 
Obesity
ObesityObesity
Obesity
 
Hyperlipidemia
HyperlipidemiaHyperlipidemia
Hyperlipidemia
 
Hocm
HocmHocm
Hocm
 
Ec gs for medical student
Ec gs  for medical studentEc gs  for medical student
Ec gs for medical student
 
Clopidogrel resistance
Clopidogrel resistanceClopidogrel resistance
Clopidogrel resistance
 
Congestive heart failure
Congestive heart failureCongestive heart failure
Congestive heart failure
 
Antibiotic choices
Antibiotic choicesAntibiotic choices
Antibiotic choices
 
Acute coronary syndrome
Acute coronary syndromeAcute coronary syndrome
Acute coronary syndrome
 
Anemiainelderly
AnemiainelderlyAnemiainelderly
Anemiainelderly
 

Contrast nephropahthy

  • 1.
  • 2. Definition • Prognosis • Pathology • Risk factor • Incidence • Prevention • Recommendation
  • 3. Case 1 • 69 y/o M with NSTEMI is going for PCI. Baseline Cr 65. 2 days post PCI Cr is 94 with good UOP . • Are you concerned about what happened?
  • 4. Case 2 • 42 y/o F in 5C3 with T2 DM with baseline Cr of 60 she is scheduled for CT abdomen for pancreatitis . • What is her risk of developing CIN?
  • 5. Case 3 • 78 y/o came with IWMI with hypotension required IABP and pressors is going for diagnostic angiogram after successful lytic therapy . Known DM with Cr 150 ,he is concerned about his kidneys . • Is there a way to predict his risk ?
  • 6. Case 4 • 65 y/o F smoker ,T2 DM with Cr 100,HTN and sever PVD underwent 1ry PCI for AWMI. Next day Cr 200 and you notice periphral cynosis with rash over Rt leg. • What is happening with her?
  • 7. Types of radiocontrast agents • First generation agents are ionic hyperosmolal monomers( 1500) • Second generation agents are nonionic monomers with a lower osmolality than the first generation (600) • The nonionic contrast agents are dimers with an osmolality ( 350)
  • 8. Definition 25% rise in serum creatinine during the first three days after the procedure is the most acceptable definition .
  • 9. Prognosis • Peak in 1-3 days • Recovery 5-10 • If creatinine >440 moslt likely progress to RF requiring HD.
  • 10. PATHOGENESIS The exact mechanism is not well understood . The two major theories, based mainly on animal studies: renal vasoconstriction(endothelin) direct toxic effects of the contrast agents.
  • 11. INCIDENCE AND RISK FACTORS The reported incidence of radiocontrast- induced nephropathy varies widely, ranging from 0- 50%.
  • 12. Who is in risk • Underlying renal insufficiency, with the plasma creatinine exceeding 132 µmol/L(4-11%) and 50% if exceeding 350µmol/L. • Diabetic nephropathy with renal insufficiency (9- 30%) • Multiple myeloma (1.5%) • Advanced heart failure or other cause of reduced renal perfusion such as hypovolemia • High total dose of contrast agent and the type of the contrast
  • 13. Normal kidney function Negligible with normal renal function, even if the patient is diabetic
  • 14. In PCI In a review of over 7500 patients undergoing a PCI for coronary heart disease, the incidence of CIN was 3.3 percent overall and approximately 25 percent in those with a baseline serum creatinine above (177 µmol/L) .
  • 16. Which of the following modalities can prevent CIN? • Lasix • Manitol • Dobutamin • Theophyline • Ca blockers • ANP • UF • HD • Statin
  • 18. Oral hydration • Few small trials have evaluated the effectiveness of oral hydration or an outpatient hydration protocol in preventing contrast nephropathy. • The results have been conflicting, some suggested that oral hydration as effective others less effective .
  • 19. Type of fluid • Prospective randomized trial of 1620 patients . The incidence of contrast-induced nephropathy was significantly lower in patients received NS than 1/2NS
  • 20. Acetylcysteine • There is inconsistency in the results of clinical trials regarding the effectiveness of NAC in prevention of contrast nephropathy . • The overall direction of the data is towards benefit .
  • 21. NaHCO3 • A prospective, single-center, randomized trial showed overall benefit of NaHCO3 compared to NS . • Issues with this study
  • 22. SUMMARY AND RECOMMENDATIONS • Indication of the procedure • The use of lower doses of contrast and avoidance of repetitive studies that are closely spaced. • Avoid of volume depletion • Avoid NSAID • Stop metformin 48h before
  • 23. Hydration Prophylactic regimen is the intravenous administration of NS at a rate of 1 mL/kg /h for 12 hours before and 12 hours after the radiographic study .
  • 24. NAC PO: 600 mg orally BID and administered the day before and the day of the procedure . IV: 150 mg/kg in 500 mL NS over 30 minutes immediately before contrast exposure, then 50 mg/kg in 500 mL NS over four hours .
  • 25. NaHCO3 • A bolus of 3 mL/kg of NaHCO3 one hour prior to the procedure, and continued at a rate of 1 mL/kg for six hours after the procedure.
  • 26. Contrast Both low osmolal and iso-osmolal nonionic agents appear to lower the risk of nephropathy .
  • 27. HD and UF • Creatinine >440 • Decrease UOP • Acidosis • Hyperkalemia
  • 28.
  • 29. Case 1 • 62 y/o M with NSTEMI is going for PCI. Baseline Cr 65. 2 days post PCI Cr is 94 with good UOP . • Are you concerned about what happened?
  • 30. Case 2 • 42 y/o F in 5C3 with T2 DM with baseline Cr of 60 she is scheduled for CT abdomen for pancreatitis . • What is her risk of developing CIN?
  • 31. Case 3 • 78 y/o came with IWMI with hypotension requiring IABP is going for diagnostic angiogram after successful lytic therapy . Known DM with Cr 150 is concerned about his kidney function. • Is there a way to predict his risk ?
  • 32.
  • 33. Case 4 • 65 y/o F smoker ,T2 DM with Cr 100,HTN and sever PVD underwent 1ry PCI for AWMI. Next day Cr 200 and you notice periphral cynosis with rash over Rt leg. • What is happening with her?
  • 34. Cholesterol embolism • Low complement • Eosinophilia • Eosinophilurea • Systemic ischemia • Acute deterioration • Last upto 8 weeks • Livedo reticularis